Details for New Drug Application (NDA): 212567
✉ Email this page to a colleague
The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 212567
Tradename: | TRIAMCINOLONE ACETONIDE |
Applicant: | Mylan Labs Ltd |
Ingredient: | triamcinolone acetonide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 212567
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 212567
Suppliers and Packaging for NDA: 212567
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | INJECTABLE;INJECTION | 212567 | ANDA | Mylan Institutional LLC | 67457-621 | 67457-621-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-621-02) / 1 mL in 1 VIAL, SINGLE-DOSE |
TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | INJECTABLE;INJECTION | 212567 | ANDA | Mylan Institutional LLC | 67457-622 | 67457-622-05 | 1 VIAL, MULTI-DOSE in 1 CARTON (67457-622-05) / 5 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 40MG/ML | ||||
Approval Date: | Nov 2, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription